Matthew T. Mefford

667 total citations
38 papers, 436 citations indexed

About

Matthew T. Mefford is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Matthew T. Mefford has authored 38 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 8 papers in Economics and Econometrics. Recurrent topics in Matthew T. Mefford's work include Lipoproteins and Cardiovascular Health (12 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (6 papers). Matthew T. Mefford is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (6 papers). Matthew T. Mefford collaborates with scholars based in United States, Canada and Australia. Matthew T. Mefford's co-authors include Paul Muntner, Robert S. Rosenson, Keri L. Monda, Vera Bittner, Kristi Reynolds, Monika M. Safford, Emily B. Levitan, Michael E. Farkouh, Todd M. Brown and Yuling Dai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew T. Mefford

35 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew T. Mefford United States	13	158	156	88	55	46	38	436
Benjamin Taylor United States	9	80 0.5×	194 1.2×	180 2.0×	40 0.7×	9 0.2×	20	376
Greg J. Zahner United States	11	115 0.7×	146 0.9×	102 1.2×	25 0.5×	14 0.3×	21	466
Julie A. Patterson United States	12	73 0.5×	33 0.2×	41 0.5×	57 1.0×	30 0.7×	46	594
Francesca Venturini Italy	13	79 0.5×	38 0.2×	97 1.1×	52 0.9×	72 1.6×	38	798
Thomas Godec United Kingdom	10	70 0.4×	86 0.6×	28 0.3×	118 2.1×	81 1.8×	24	383
Katherine L. Hull United Kingdom	10	55 0.3×	106 0.7×	27 0.3×	26 0.5×	71 1.5×	27	501
José I. Cuende Spain	10	207 1.3×	101 0.6×	29 0.3×	75 1.4×	25 0.5×	30	504
Andrew MN Walker United Kingdom	15	292 1.8×	56 0.4×	43 0.5×	57 1.0×	11 0.2×	31	600
Narendra C. Bhalodkar United States	9	113 0.7×	99 0.6×	24 0.3×	123 2.2×	6 0.1×	15	330
Tina K. Reddy United States	6	115 0.7×	54 0.3×	29 0.3×	45 0.8×	24 0.5×	13	303

Countries citing papers authored by Matthew T. Mefford

Since Specialization

Citations

This map shows the geographic impact of Matthew T. Mefford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew T. Mefford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew T. Mefford more than expected).

Fields of papers citing papers by Matthew T. Mefford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew T. Mefford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew T. Mefford. The network helps show where Matthew T. Mefford may publish in the future.

Co-authorship network of co-authors of Matthew T. Mefford

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew T. Mefford. A scholar is included among the top collaborators of Matthew T. Mefford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew T. Mefford. Matthew T. Mefford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mefford, Matthew T., Hui Zhou, Lori D. Bash, et al.. (2025). Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California. The American Journal of Cardiology. 255. 55–63.

Rivera, Adovich S., et al.. (2023). Changes in Glomerular Filtration Rate After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for Human Immunodeficiency Virus Preexposure Prophylaxis. Open Forum Infectious Diseases. 11(2). ofad695–ofad695.

Mefford, Matthew T., Rong Wei, Eva Lustigova, John Martin, & Kristi Reynolds. (2023). Incidence of Diabetes Among Youth Before and During the COVID-19 Pandemic. JAMA Network Open. 6(9). e2334953–e2334953. 15 indexed citations

Rivera, Adovich S., et al.. (2023). Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins. JAMA Network Open. 6(9). e2332968–e2332968. 9 indexed citations

Mefford, Matthew T., Jamal S. Rana, Kristi Reynolds, et al.. (2022). Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions. JAMA Network Open. 5(4). e228031–e228031. 3 indexed citations

Mefford, Matthew T., Ran Liu, Lei Qian, et al.. (2021). Abstract MP41: Rates Of Acute Myocardial Infarction Around The Covid-19 Pandemic And Comparable Time Periods In 2019 In An Integrated Healthcare Delivery System. Circulation. 143(Suppl_1).

Mefford, Matthew T., Ligong Chen, Cora E. Lewis, et al.. (2021). Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study. Journal of the International Neuropsychological Society. 27(10). 1048–1057. 9 indexed citations

Mefford, Matthew T., Ran Liu, Katia Bruxvoort, et al.. (2021). Influenza vaccination and mortality among adults with heart failure in an integrated healthcare delivery system, 2009–2018. Journal of General Internal Medicine. 37(10). 2405–2412. 4 indexed citations

Mefford, Matthew T., Wansu Chen, Heather Watson, et al.. (2021). Temporal trends in heart failure mortality in an integrated healthcare delivery system, California, and the US, 2001–2017. BMC Cardiovascular Disorders. 21(1). 261–261. 4 indexed citations

10.

Mefford, Matthew T., Bonnie H. Li, Lei Qian, et al.. (2020). Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014. Circulation. 141(7). 509–519. 26 indexed citations

11.

Safford, Monika M., Matthew T. Mefford, George Howard, et al.. (2020). Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults. Circulation Cardiovascular Quality and Outcomes. 13(12). e006683–e006683. 18 indexed citations

12.

Mefford, Matthew T., Santica M. Marcovina, Vera Bittner, et al.. (2019). PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults. Journal of Lipid Research. 60(11). 1946–1952. 8 indexed citations

13.

Bittner, Vera, Lisandro D. Colantonio, Yuling Dai, et al.. (2019). Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries. JAMA Cardiology. 4(9). 865–865. 19 indexed citations

14.

Mefford, Matthew T., Melissa K. Van Dyke, Ligong Chen, et al.. (2019). Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study). The American Journal of Cardiology. 123(10). 1667–1674. 2 indexed citations

15.

Mefford, Matthew T., et al.. (2017). Validation of the BioPRYN enzyme‐linked immunosorbent assay for detection of pregnancy‐specific protein‐B (PSPB) and diagnosis of pregnancy in American bison (Bison bison). Reproduction in Domestic Animals. 52(5). 791–797. 5 indexed citations

16.

Donnelly, John P., Carrie Huisingh, Matthew T. Mefford, et al.. (2017). Self-reported vs state-recorded motor vehicle collisions among older community dwelling individuals. Accident Analysis & Prevention. 101. 22–27. 14 indexed citations

17.

Mefford, Matthew T., Monika M. Safford, Paul Muntner, et al.. (2017). Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study. International Journal of Cardiology. 236. 462–465. 5 indexed citations

18.

Rosenson, Robert S., Michael E. Farkouh, Matthew T. Mefford, et al.. (2017). TRENDS IN THE USE OF HIGH-INTENSITY STATIN THERAPY AFTER MYOCARDIAL INFARCTION, 2011-2014. Journal of the American College of Cardiology. 69(11). 235–235. 2 indexed citations

19.

Mefford, Matthew T., Robert S. Rosenson, Mary Cushman, et al.. (2017). PCSK9 VARIANTS AND NEUROCOGNITIVE IMPAIRMENT: DATA FROM THE REASONS FRO GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) STUDY. Journal of the American College of Cardiology. 69(11). 1652–1652. 1 indexed citations

20.

Rosenson, Robert S., Michael E. Farkouh, Matthew T. Mefford, et al.. (2017). Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014. Journal of the American College of Cardiology. 69(22). 2696–2706. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact